- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 5 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x EPU: URIDINE-DIPHOSPHATE-2(N-ACETYLGLUCOSAMINYL) BUTYRIC ACID(Non-covalent)
EPU.2: 24 residues within 4Å:- Chain A: K.22, N.23, L.26, W.95, I.117, R.120, P.121, V.122, D.123, L.124, H.125, K.160, S.162, V.163, G.164, T.304, D.305, I.327, F.328, R.331, L.370, R.371
- Ligands: PO4.1, GOL.3
31 PLIP interactions:31 interactions with chain A- Hydrophobic interactions: A:L.26, A:W.95, A:I.117
- Hydrogen bonds: A:N.23, A:D.123, A:L.124, A:H.125, A:K.160, A:S.162, A:V.163, A:G.164, A:E.188, A:D.305, A:R.331
- Water bridges: A:R.120, A:R.120, A:R.120, A:S.162, A:R.232, A:R.232, A:T.304, A:T.304, A:T.304, A:E.329, A:R.331, A:R.331
- Salt bridges: A:K.22, A:R.120, A:R.120, A:R.331, A:R.371
EPU.6: 23 residues within 4Å:- Chain B: K.22, N.23, L.26, W.95, R.120, P.121, V.122, D.123, L.124, H.125, K.160, S.162, V.163, G.164, T.304, D.305, I.327, F.328, R.331, L.370, R.371
- Ligands: PO4.5, GOL.7
32 PLIP interactions:32 interactions with chain B- Hydrophobic interactions: B:L.26, B:W.95
- Hydrogen bonds: B:N.23, B:N.23, B:D.123, B:L.124, B:H.125, B:K.160, B:S.162, B:V.163, B:G.164, B:D.305, B:R.331
- Water bridges: B:R.120, B:R.120, B:R.120, B:S.162, B:E.188, B:E.188, B:R.232, B:R.232, B:T.304, B:T.304, B:T.304, B:I.327, B:E.329, B:E.329
- Salt bridges: B:K.22, B:R.120, B:R.120, B:R.331, B:R.371
EPU.10: 24 residues within 4Å:- Chain C: K.22, N.23, L.26, W.95, I.117, R.120, P.121, V.122, D.123, L.124, H.125, K.160, S.162, V.163, G.164, T.304, D.305, I.327, F.328, R.331, L.370, R.371
- Ligands: PO4.8, GOL.11
35 PLIP interactions:35 interactions with chain C- Hydrophobic interactions: C:L.26, C:W.95, C:I.117
- Hydrogen bonds: C:N.23, C:N.23, C:D.123, C:L.124, C:H.125, C:S.162, C:V.163, C:G.164, C:E.188, C:E.188, C:D.305, C:R.331
- Water bridges: C:R.91, C:R.120, C:R.120, C:R.120, C:K.160, C:K.160, C:K.160, C:K.160, C:R.232, C:R.232, C:T.304, C:T.304, C:T.304, C:I.327, C:E.329, C:E.329
- Salt bridges: C:K.22, C:R.120, C:R.331, C:R.371
EPU.13: 24 residues within 4Å:- Chain D: K.22, N.23, L.26, W.95, R.120, P.121, V.122, D.123, L.124, H.125, K.160, S.162, V.163, G.164, E.188, T.304, D.305, I.327, F.328, R.331, L.370, R.371
- Ligands: PO4.12, GOL.14
32 PLIP interactions:32 interactions with chain D- Hydrophobic interactions: D:L.26, D:W.95
- Hydrogen bonds: D:N.23, D:N.23, D:D.123, D:L.124, D:H.125, D:S.162, D:V.163, D:G.164, D:E.188, D:D.305, D:R.331
- Water bridges: D:R.91, D:R.120, D:R.120, D:R.120, D:K.160, D:K.160, D:K.160, D:K.160, D:R.232, D:R.232, D:T.304, D:T.304, D:E.329, D:R.331
- Salt bridges: D:K.22, D:R.120, D:R.120, D:R.331, D:R.371
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 9 residues within 4Å:- Chain A: R.91, A.92, I.94, W.95, R.120, H.125, G.164
- Ligands: PO4.1, EPU.2
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.91, A:W.95, A:R.120
- Water bridges: A:R.91, A:H.125
GOL.4: 2 residues within 4Å:- Chain A: R.252, S.281
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.252, A:R.252, A:S.281
GOL.7: 9 residues within 4Å:- Chain B: R.91, A.92, I.94, W.95, R.120, H.125, G.164
- Ligands: PO4.5, EPU.6
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:R.91, B:W.95, B:R.120
- Water bridges: B:R.120, B:H.125
GOL.11: 8 residues within 4Å:- Chain C: R.91, A.92, W.95, R.120, H.125, G.164
- Ligands: PO4.8, EPU.10
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:R.91, C:W.95, C:R.120
- Water bridges: C:R.91, C:H.125, C:G.164
GOL.14: 9 residues within 4Å:- Chain D: R.91, A.92, I.94, W.95, R.120, H.125, G.164
- Ligands: PO4.12, EPU.13
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:R.91, D:W.95, D:R.120
- Water bridges: D:G.164, D:G.164
GOL.15: 3 residues within 4Å:- Chain D: V.250, R.252, W.279
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:R.252, D:R.252
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Eschenburg, S. et al., Evidence That the Fosfomycin Target Cys115 in UDP-N-acetylglucosamine Enolpyruvyl Transferase (MurA) Is Essential for Product Release. J.Biol.Chem. (2005)
- Release Date
- 2004-11-09
- Peptides
- UDP-N-acetylglucosamine 1-carboxyvinyltransferase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 5 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x EPU: URIDINE-DIPHOSPHATE-2(N-ACETYLGLUCOSAMINYL) BUTYRIC ACID(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Eschenburg, S. et al., Evidence That the Fosfomycin Target Cys115 in UDP-N-acetylglucosamine Enolpyruvyl Transferase (MurA) Is Essential for Product Release. J.Biol.Chem. (2005)
- Release Date
- 2004-11-09
- Peptides
- UDP-N-acetylglucosamine 1-carboxyvinyltransferase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H